Iris | Vitabase

Other Names

Beard irisBearded irisBlue flagBlue flag rootBlue flower de luceBlue irisDaggersDalmatian irisDragon flowerEye of heavenFlagFlag irisFlag lilyFlaggonFleur de luceFleur-de-lisFliggersFlorentine irisFlorentinische SchwertlilieFlower de-luceGarden irisGerman irisGladyneHarlequin blueflagIris acoriformisIris acoroidesIris aquaticaIris bastardiiIris boltonianaIris caurinaIris curtopetalaIris de florenceIris dierinckiiIris flaccidaIris flavaIris florentinaIris germanicaIris luteaIris lutiaIris pallidaIris pallidecaeruleaIris pallidiorIris paludosaIris palustrisIris pictaIris pseudacorusIris versicolorIris virginicaJacob's swordLa flambe blancheLarger blue flagLeversLimnirion pseudacorusLimniris pseudacorusLimniris versicolorLirio blancoLirio de FlorenciaLiver lilyLiversMeklinMyrtle flowerNorthern blue flagOil of orrisOrrisOrris butterOrris rootPale yellow irisPoison flagPurple flagPurple irisQueen Elizabeth rootRhizoma iridisSeggShalderSheggsSnake lilySweet irisTall bearded irisViolrodWater flagXiphion pseudacorusXiphion versicolorXyridion pseudacorusYellow flagYellow irisYellowflag iris

Synopsis

Iris (Iris spp.) — A Comprehensive Encyclopedic Reference

1. Identity: Botanical Classification, Nomenclature, and Forms

1.1 Taxonomy and Recognized Species

The genus Iris, belonging to the family Iridaceae, consists of more than 262 recognized species. It is an ornamental and medicinal plant widely distributed in the Northern Hemisphere. The genus Iris is a well-reputed rhizomatous plant belonging to the Iridaceae, a family of herbaceous, perennial, and bulbous plants.

Several distinct species have historically been of particular medicinal or commercial significance. The most important are:

Iris germanica L. (German iris, bearded iris) — the principal source of orris root in European and Persian medicine.
Iris pallida Lam. — a close ally of I. germanica, co-cultivated for orris root production in the Tuscany region of Italy.
Iris florentina L. (Florentine iris, white iris) — historically referred to as the white iris and considered an old name for Iris germanica.
Iris versicolor L. (blue flag iris) — a North American species, principally used in Indigenous and Eclectic medicine.
Iris domestica (L.) Goldblatt & Mabb. (leopard flower, formerly Belamcanda chinensis) — this species had been placed in a separate genus Belamcanda as its sole species, B. chinensis; however, recent molecular DNA sequence evidence showed B. chinensis nested within the genus Iris.
Iris tectorum Maxim. — a Chinese and Japanese species noted as a secondary source of tectorigenin.

1.2 Botanical Description

Iris is a perennial, aquatic plant that forms a clump of narrow, arching-to-erect, sword-shaped, blue-dark green leaves approximately 24 inches long and one inch wide. Flowering stalks arise from the clump and grow up to 30 inches tall in late spring; each stalk produces between 3–5 bluish-violet coloured flowers with bold purple veining. Clumps spread by tough, creeping rhizomes at a moderate rate.

1.3 Pharmacopoeial Names and Common Preparations

The specific species typically cultivated for orris root include Iris germanica, Iris pallida, and historically Iris florentina. In pharmacopoeias, orris root is referred to as Rhizoma iridis, a designation that specifies the dried rhizomes of these Iris species.

The chief economic and medicinal use of the iris at the present time involves the production of Orris Root (Rhizoma Iridis), derived from I. germanica, I. pallida, and I. florentina, collected indiscriminately in Italy from these three species, and largely cultivated for their rhizomes in Southern Europe, mostly on the mountain slopes.

Iris domestica (syn. Belamcanda chinensis), under the Chinese name she gan, is extensively used in Traditional Chinese Medicine and other East Asian phytotherapy systems. The monograph of Belamcandae chinensis rhizoma has been included in the European Pharmacopoeia.

Common preparation forms across species include:

Dried and aged rhizomes (orris root), powdered root
Tinctures and fluid extracts
Essential oils (orris butter or orris concrete), obtained from aged rhizomes
Standardized aqueous or ethanolic rhizome extracts
Tea decoctions and infusions
Topical preparations (pastes, creams, lotions, cosmetic extracts)
Orris root is generally used in combination with other herbs and can be found in homeopathic dilutions and tea preparations.

1.4 The Aging and Orris Fragrance

When fresh, the rhizomes are odourless. They have to be dried for up to five years, and over time the scent will develop as substances in the rhizome oxidize. The fragrance is attributed to irones formed during rhizome storage by oxidative degradation of iridals. The essential oil of I. florentina rhizomes aged for only 3 months had merely 4% α-irone and 8% γ-irone, while essential oil from I. germanica rhizomes aged for approximately one and a half to two years had 30–31% α-irone and 55–59% γ-irone content.

2. Traditional and Historical Use

2.1 Ancient Mediterranean: Greece, Rome, and the Near East

Iris species convey a long history as valuable traditional drugs with a wide variety of applications in various cultures, having been recorded since medieval times. Theophrastus and Dioscorides were well acquainted with orris root; Dioscorides and Pliny remark that the best comes from Illyricum (the modern Dalmatia).

As early as in antiquity, orris root was applied to treat stomach illnesses and irritation as well as, above all, stomatitis and sore throat. It was also used as a remedy for respiratory tract infections, skin ulcers, and kidney stones due to its powerful diuretic effect.

Apart from its anti-inflammatory and antiseptic properties, it had a very pleasant aroma, which is why it became an ingredient of perfumed products, such as scented soaps, as well as tooth powders, which also had cleansing and medicinal properties.

2.2 Egyptian Antiquity

The utilization of orris root dates back to ancient civilizations, including the Egyptians and Greeks around 1500 BCE. It was employed in perfumes, medicines, and rituals, valued for its purifying and aromatic properties. Egyptian tombs have revealed its use in embalming and cosmetics, while in Greece it was part of garlands and ointments.

2.3 Medieval Europe and Florence

The ancient arms of Florence — a white lily or iris on a red shield — seem to indicate that the city was famed for the growth of these plants. A writer of the thirteenth century, Petrus de Crescentiro of Bologna, mentions the cultivation of the white, as well as of the purple iris, and states at what season the root should be collected for medicinal use.

The roots of iris as used for medicine are referenced in historical texts as far back as medieval times. It is described to have been blended with other herbs such as hyssop (Hyssopus officinalis) to treat skin conditions.

2.4 Persian and Central Asian Traditions

Iris germanica L. is a medicinal plant that has a long history of uses, mainly in medieval Persia and many places worldwide for the management of a wide variety of diseases. Ethnomedical uses of I. germanica have been reported from many countries such as China, Pakistan, India, Iran, and Turkey.

2.5 Traditional Chinese Medicine: Iris domestica (She Gan)

The rhizomes of B. chinensis have a long history of use as a traditional herbal medicine in China, recognized for its effects in clearing heat, detoxifying and eliminating phlegm, and soothing the throat. The plant is primarily found in China, but with additional distribution in North Korea, South Korea, Japan, and India.

For thousands of years in China, the rhizome of Belamcanda chinensis has been used to treat inflammation, oxyhepatitis, mumps, acute mastitis, and asthma, as well as throat disorders such as cough, tonsillitis, and pharyngitis. Currently, more than ten proprietary Chinese medicines on the market containing B. chinensis are included in the Chinese Pharmacopoeia (2020 Edition), with clinical applications addressing cough with phlegm, sore throat, chest tightness, and abdominal distension. Two approved Chinese patent medicines, She Gan Li Yan Kou Fu Ye and She Gan Kang Bing Du Zhu She Ye, utilize B. chinensis as a primary ingredient, specifically for antiviral purposes and sore throat treatment.

2.6 Indigenous North American Use: Iris versicolor

Iris versicolor has a storied heritage among Native American tribes, particularly in the northeastern United States and eastern Canada. The Iroquois used blue flag preparations as a purgative and diuretic, sometimes to treat menstrual irregularities or as a topical application for inflammations and skin ulcers. Documented references to "blue flag root" appear in the journals of 18th-century colonial botanists like John Bartram, and it was first formally described by Carl Linnaeus in 1753.

Iris versicolor was widely used by Indigenous Americans for digestive problems. In the nineteenth century, physicians of the Eclectic school of medicine also used blue flag for digestive problems and to treat thyroid enlargement, enhance immunity, stimulate the liver, and "detoxify" the body.

2.7 Other Documented Traditional Uses

In official and traditional medicine in Asia and Europe, the underground and aboveground parts of Iris aphylla, I. lactea, I. pseudacorus, I. ruthenica, I. sanguinea, and other species of the genus are used.

Iris bulbs have been used traditionally for goiter, both topically and internally, to improve sluggish metabolic function and to move bodily fluids including saliva, lymph, bile, and digestive secretions.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Profile

In the genus Iris, phenolic acids, an abundance of flavonoids, small amounts of alkaloids, primary metabolites, and essential oils have been identified. Iris leaves are a rich source of phenolic acids such as ferulic, p-coumaric, sinapic, caffeic, chlorogenic, neochlorogenic, p-hydroxybenzoic, and vanillic acids.

Most of the isolated metabolites are flavonoids, isoflavonoids, anthocyanins, terpenoids, xanthones, quinones, phenolic acids, and fatty acids.

3.2 Isoflavones and Isoflavonoids

Several isoflavones such as irigenin, tectorigenin, and irisolone have only been reported in the Iris genus. Isoflavonoids that contain a methylenedioxy group in ring A (such as irilon, irisolidone, nigricin, tectoridin, etc.) are rather rare in the plant kingdom.

Irigenin (5,7,3′-trihydroxy-6,4′,5′-trimethoxyisoflavone) and iristectorigenin A (5,7,3′-trihydroxy-6,4′-dimethoxyisoflavone), along with their 7-O-β-D-glucosides, iridin and iristectorin A respectively, have been found as the major isoflavone components in Iris germanica.

Previous in vitro investigations showed that the isoflavones in rhizomes have a number of biological activities, including anti-mutagenic, anti-inflammatory, anti-angiogenic, and anti-tumour activities, as well as inhibiting lipid peroxidation and scavenging free radicals. Among the active isoflavones, O-glycosylated compounds such as tectoridin and iridin are the main ingredients.

3.3 Tectorigenin and Tectoridin

Tectorigenin is a well-known natural flavonoid aglycone and an active component that exists in numerous plants. Growing evidence suggests that tectorigenin has multiple pharmacological effects, such as anticancer, antidiabetic, hepatoprotective, anti-inflammatory, antioxidative, antimicrobial, cardioprotective, and neuroprotective. These pharmacological properties provide the basis for the treatment of many kinds of illnesses, including several types of cancer, diabetes, hepatic fibrosis, osteoarthritis, Alzheimer's disease, and others.

The diverse pharmacological properties of tectoridin and tectorigenin, two phytoestrogens derived from natural products, are highlighted in the literature. Tectoridin and tectorigenin are prominent isoflavonoids found in the rhizomes of Iris domestica (L.) Goldblatt & Mabb., Iridaceae (Belamcandae Rhizoma).

3.4 Iridals and Irones (Terpenoids)

Iridals and consequently irones, along with isoflavonoids, are the main bioactive compounds in orris root. Iridals show strong pesticidal and anti-cancer properties, while tectorigenin, as an isoflavone, had interesting activity against hormone-related diseases. The essential oil of orris root, which is a rich source of irones, has been widely used in cosmetics and perfume industries.

The main group of phytochemicals identified in the dried rhizoma are polyphenols such as isoflavones, xanthone glycosides, stilbenes, simple phenols, and quinones. Another characteristic class of substances are triterpenoid iridals.

3.5 Other Phenolic Compounds and Flavonoids

Based on phytochemical investigations of I. germanica, different bioactive compounds including flavonoids, triterpenes, sterols, phenolics, ceramides, and benzoquinones have been identified in its medicinal parts.

Stress metabolites from Iris pseudacorus leaves were found to include 10 isoflavones: 5,2′-dihydroxy-6,7-dimethoxyisoflavone (irilin A), 5,7,2′-trihydroxy-6-methoxyisoflavone (irilin B), 5,7,2′-trihydroxyisoflavone (irilin C), iristectorigenins A and B, tectorigenin, 3′-O-methylorobol, pratensein, biochanin A, and genistein.

The C-diglucoside flavone embinin was isolated from flowers and leaves, the 6-C-glucoside flavone isovitexin was isolated from flowers, the stilbenoid (−)-trans-resveratrol-3-O-β-d-glucopyranoside was found in rhizomes, and the isoflavone (+)-tectorigenin was isolated from bulbs.

According to previous studies, I. pallida resinoids are rich in flavonoids, of which irigenin is the most abundant. HPLC-DAD analysis confirmed that irigenin is the main component of I. pallida extract (IPE), accounting for 0.63% of the total content of IPE.

4. Mechanisms of Action

4.1 Anti-Inflammatory Pathways

Tectorigenin appears to exert its pharmacological effects via modulating signalling pathways, including PPARγ/NF-κB, PI3K/AKT, TLR4/NF-κB, IKKβ/NF-κB/JNK, ERK/JNK, MAPK/JNK/AP-1, AKT/MAPK, and TGF-β1/Smad.

Tectorigenin suppressed the LPS-induced activation of nuclear factor-κB (NF-κB), phosphorylation of extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) to regulate the inflammatory mediators, including inducible nitric oxide synthase (iNOS).

Numerous studies have shown that tectoridin and tectorigenin possess significant anti-inflammatory activity through the regulation of various pathways, including the ERK-mitogen-activated protein kinase (MAPK) pathway.

4.2 Antioxidant Mechanisms

Mechanistic investigations revealed tectorigenin's ability to potentiate ERK phosphorylation and nuclear translocation of nuclear factor kappa-B (NF-κB), whereas pharmacological blockade of these pathways compromised its antioxidative efficacy. Available literature indicates that Belamcandae chinensis rhizoma can prevent excessive oxidation of biomolecules based on various antioxidant mechanisms: transition metal ion reduction, inhibition of lipid peroxidation, and free radical scavenging.

4.3 Estrogenic / Phytoestrogenic Activity

Tectorigenin has been reported to exert selective estrogen receptor modulation. Most pharmacological research on Belamcandae chinensis rhizoma has focused on isoflavones and their estrogenic properties.

4.4 Anticancer / Cytotoxic Mechanisms

Potent cytotoxic and antitumour agents effective against various malignancies, including prostate, breast, colon, lung, leukaemia, ovarian, and liver cancers, are exhibited by tectoridin and tectorigenin through modulation of multiple signalling pathways involved in migration, apoptosis, cell proliferation, and invasion.

In an MTT assay, embinin showed significant inhibitory activity that was higher than the well-known antitumour drug cisplatin, against MCF7, SkBr3, Ishikawa, BG-1, and A549 human tumour cells. Moreover, embinin showed remarkable DPPH radical scavenging activity comparable to that of the well-known antioxidant ascorbic acid. (These are preclinical, in vitro results only.)

4.5 Glucocorticoid Receptor Antagonism (Skin)

Iris pallida extract (IPE) rescued the suppression of the gene expression of COL1A1 and the hyaluronic acid synthases HAS2 and HAS3 in cortisol-exposed cells. Moreover, IPE blocked the cortisol-induced translocation of the glucocorticoid receptor (GR) from the cytoplasm to the nucleus as effectively as the GR inhibitor mifepristone.

4.6 Nitric Oxide Suppression

The production of nitric oxide (NO) was inhibited in a dose-dependent manner by isolated compounds from Iris spuria, along with isoflavonoids, in LPS-stimulated macrophage models.

4.7 Pharmacokinetics of Key Compounds

Pharmacokinetic studies have demonstrated that the main metabolic pathways in rats for tectorigenin are glucuronidation, sulfation, demethylation, and methoxylation, but that it exhibits poor bioavailability.

5. Scientific Evidence by Area of Use

Important framing note: The overwhelming majority of published pharmacological evidence for Iris species derives from in vitro (cell-based) and animal experiments. Robust, controlled human clinical trials are rare. This is explicitly noted below for each area.

5.1 Anti-Inflammatory Activity

Extracts and compounds isolated from most studied Iris species exhibit analgesic, antioxidative, antipyretic, anti-inflammatory, antibacterial, and antimicrobial activity. Previous in vitro investigations showed that isoflavones in rhizomes have a number of biological activities, including anti-mutagenic, anti-inflammatory, and anti-angiogenic activities, as well as inhibiting lipid peroxidation and scavenging free radicals.

The evidence for anti-inflammatory activity is supported primarily by in vitro cell line studies and by the existence of an approved pharmaceutical preparation. "Laktir," a medication in the form of coated tablets made from the dried extract of milk-white iris, is extensively recommended as an anti-inflammatory agent to cure acute and chronic inflammatory disorders. This represents one of the few formalized clinical-use products based on Iris extracts, though extensive peer-reviewed clinical trial data on this specific product are not widely available in indexed literature.

Evidence strength: Strong in vitro and animal evidence; limited but existing clinical product use; controlled human RCT evidence is largely absent.

5.2 Respiratory and Throat Conditions

Belamcanda chinensis, known as She Gan, has been used in Traditional Chinese Medicine for the clinical treatment of respiratory diseases including bronchitis, asthma, sore throat, and related conditions. Belamcanda chinensis has been reported to have antipyretic, antidote, expectorant, antiphlogistic, and analgesic activity in the scientific fields.

The primary active components in Belamcanda chinensis possess a wide range of pharmacological activities, including anti-inflammatory, anti-oxidative, anti-tumour, anti-alcohol injury, cardiovascular, and oestrogenic activities. As an important traditional Chinese medicine, Belamcanda chinensis has been demonstrated to have marked bioactivity, especially in the respiratory system.

Evidence strength: Traditional use is very well-documented; pharmacological rationale exists from in vitro studies; Chinese Pharmacopoeia approval provides regulatory recognition. Large-scale independent human RCTs specific to Iris domestica extracts for respiratory conditions are limited in indexed Western literature.

5.3 Anticancer Activity

While all tested compounds were able to limit cancer growth in a dose-dependent manner in both A549 (lung) and Caco-2 (colon) cells, tectorigenin was most effective among them, with IC50 values of 7.15 μM for A549 and 23.39 μM for Caco-2. Iridin and tectorigenin were also observed to cause a dose-dependent downregulation of KRAS expression in A549 cells, supporting their anti-cancer capabilities.

In LNCaP (androgen-sensitive human prostate carcinoma cells) cell cultures, Belamcandae rhizoma extract and several belamcanda isoflavonoids downregulated androgen receptor expression at both mRNA and protein levels, PSA expression and secretion, as well as the expression of the prostate cancer-specific marker DD3PCA3. In addition, the IGF-1 receptor (insulin-like growth factor 1 receptor) mRNA expression and androgen-dependent hTERT (a telomerase subunit) mRNA expression were strongly reduced by treatment with belamcanda phytochemicals.

Evidence strength: Preclinical (in vitro and some animal models) evidence is substantial. There are no published human clinical trials confirming anticancer efficacy of whole Iris extracts or isolated compounds. All anticancer data must be considered preliminary.

5.4 Antioxidant Activity

Many empirical uses of Iris spp. have been validated by in vitro and in vivo studies, showing that Iris spp. exhibit potent antioxidant, anticancer, anti-inflammatory, hepatoprotective, neuroprotective, and anti-microbial properties. Phytochemical investigations have revealed that plant extracts are rich in phenolic compounds, especially flavonoids and phenolic acids, and as such they constitute a promising lead for seeking new drugs with high susceptibilities towards various health issues, particularly oxidative-stress-related diseases such as cancers, neurodegenerative diseases, cardiovascular diseases, and diabetes.

Evidence strength: Well-established in vitro antioxidant activity; extrapolation to clinical human outcomes has not been demonstrated in controlled trials.

5.5 Skin and Dermatological Applications

A 2023 peer-reviewed study published in Current Issues in Molecular Biology (PMC) investigated the effect of Iris pallida extract on human skin cells. Iris pallida, used in traditional medicine and perfumes, exhibits biological activities such as antioxidant and anti-inflammatory activities. In this study, researchers investigated the inhibitory effect of IP extract (IPE) on cortisol activity in human skin cells. They found that IPE alleviated the cortisol-induced decrease in the levels of procollagen type 1 and hyaluronic acid (HA), which were significantly recovered by 106% and 31%, respectively. IPE also rescued the suppression of the gene expression of COL1A1 and the HA synthases HAS2 and HAS3 in cortisol-exposed cells. Moreover, IPE blocked the cortisol-induced translocation of the glucocorticoid receptor (GR) from the cytoplasm to the nucleus as effectively as the GR inhibitor mifepristone.

This was a cellular (in vitro) study on human dermal fibroblasts (HDFs) and keratinocytes (HaCaT cells). Cells were treated with IPE at various concentrations (12.5, 25, 50, 100, 200, and 500 μg/mL) for 48 h with or without cortisol (1 μM).

Evidence strength: Promising in vitro evidence in human cell lines; no clinical trial data in human subjects for these specific dermal endpoints.

5.6 Hepatoprotective Activity

Hepatoprotective, antihyperglycemic, and anti-alcoholism activities are demonstrated by tectoridin and tectorigenin. The antioxidant properties of tectorigenin may help mitigate streptozotocin-induced toxicity and contribute to its hypoglycemic and hypolipidemic effects.

Evidence strength: Hepatoprotective data derive from in vitro assays and animal (rodent) models. No peer-reviewed human clinical trials are indexed in PubMed confirming hepatoprotective effects in patients.

5.7 Neuroprotective Activity

Tectorigenin is an active component of traditional medicine isolated from Pueraria thunbergiana Benth, Belamcanda chinensis, and Iris unguicularis. It has been reported to exert pharmacological actions including antitumour and antibacterial effects, free radical neutralization, and selective estrogen receptor modulation. Additionally, TEC was found to inhibit interferon-γ/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells.

Evidence strength: Neuroprotective activity shown in murine cell and animal models; no human clinical trial data available.

5.8 Digestive and Biliary Uses (Blue Flag / I. versicolor)

Traditional herbal texts suggest these constituents stimulate the parasympathetic nervous system, leading to production of bile, saliva, and sweat. However, modern clinical trials have not confirmed these effects for blue flag.

Theories on blue flag's medical usefulness are based on anecdotes, traditional medicine, and animal studies. Double-blind, placebo-controlled human clinical trials are necessary. Blue flag has not undergone any meaningful scientific study.

Evidence strength: Traditional use is well-documented across multiple Indigenous and Eclectic medical traditions; no meaningful controlled human clinical evidence exists.

5.9 Weight Management (Animal Studies Only)

There are no human clinical studies on Iris, but animal studies using a formula including Iris versicolor have shown the formula to promote weight loss via increased metabolic rate and enhanced lipolysis of stored fat. The proposed mechanism by the study authors was activation of noradrenalin in obese rats.

Evidence strength: Animal data only; not applicable to human supplementation at this time.

5.10 Anti-Mutagenic Activity

Isoflavonoid fractions obtained from a methanolic extract of Belamcanda chinensis rhizomes inhibited chemically induced mutations in Salmonella typhimurium TA98 and TA100 in the Ames test. Fractions enriched in isoflavonoids, obtained by sequential liquid-liquid extraction, inhibited indirect mutagenesis in TA98 almost completely, while in TA100 the maximum inhibition ranged between 80% and 100% depending on the test fraction. The inhibition of direct mutagenesis was lower, reaching about 50% in TA98 and in TA100, and was dose-dependent in the latter strain.

Evidence strength: Bacterial assay (in vitro); no animal or human data for anti-mutagenic endpoints.

6. Body Systems and Health Areas Associated with Iris

Integumentary system (skin): Anti-inflammatory, antioxidant, collagen synthesis support (in vitro), traditional topical use for ulcers and skin conditions.
Respiratory system: TCM use for throat disorders, bronchitis, asthma (particularly I. domestica); pharmacological expectorant and antiphlogistic activity documented.
Hepatobiliary system: Traditional use for liver stimulation and bile flow; tectorigenin shows hepatoprotective effects in animal models.
Lymphatic and glandular system: Modern herbalists most commonly use iris for conditions of the lymphatic and integumentary systems, as it possesses a number of effects in supporting the elimination of toxins and metabolic waste products from the body.
Gastrointestinal system: The rhizome of Iris versicolor contains several bioactive constituents including flavonoids, alkaloids, and saponins, which contribute to its therapeutic effects. Iris versicolor primarily acts on the gastrointestinal system, promoting bile secretion and influencing the mucous membranes.
Endocrine / hormonal system: Phytoestrogenic isoflavones; selective estrogen receptor modulation by tectorigenin (preclinical).
Nervous system: Neuroprotective activity and anti-neuroinflammatory effects of tectorigenin in microglia (preclinical).
Oncological (preclinical only): In vitro evidence for activity against multiple cancer cell lines through various mechanisms.
Perfumery and cosmetics: Iris spp. still find application in numerous fields, including cosmetics, pharmaceutics, and the food industry.

7. Dosage Forms and Doses Reported in Studies

The following dosages are reported strictly as they appear in cited sources, without independent endorsement:

Blue flag tincture (Iris versicolor): Herbalists sometimes recommend up to 10 drops of tincture.
Orris root in multi-herb formulas: Because iridin is potentially irritating to mucous membranes, Iris preparations are usually used in fairly small dosages and are often mixed with other plants to prevent oral or digestive irritation. Many formulas dose just 100–200 mg at a time.
Iris pallida extract in cell culture research: Cells were treated with IPE at various concentrations (12.5, 25, 50, 100, 200, and 500 μg/mL) for 48 h.
Orris root as a food flavouring: Orris root is likely safe in the small amounts used as a flavouring ingredient in foods.

No well-validated standardized clinical dosing protocol for medicinal Iris preparations has been established in peer-reviewed indexed literature. The absence of robust clinical trials makes it impossible to specify evidence-based therapeutic doses.

8. Safety Considerations and Known Interactions

8.1 Toxicity of Fresh vs. Dried/Processed Preparations

Orris root is likely safe in the small amounts used as a flavouring ingredient in foods. However, there is not enough reliable information to know if orris root that has been dried and peeled is safe to use at medicinal doses, and it is possibly unsafe to use the fresh plant juice or root. The fresh root can cause severe irritation of the mouth, as well as stomach pain, vomiting, and bloody diarrhea.

Blue flag (Iris versicolor) is considered likely unsafe when taken by mouth at high doses. It can cause nausea and vomiting, and the fresh root can irritate the mouth, throat, digestive tract, and skin.

8.2 Gastrointestinal Effects

Used in high doses, iris can have an emetic effect (causes nausea and vomiting). In smaller doses, however, iris is considered useful for treating nausea.

8.3 Allergic Contact Dermatitis

Allergic contact dermatitis to Iris germanica root in cosmetic preparations has been reported in the peer-reviewed dermatological literature (PubMed indexed case reports). Orris root powder was widely used in face powders and other cosmetics until people noticed it was causing allergic reactions. Beyond ingestion, direct skin contact with the sap or other parts of the plant can cause dermatitis, characterized by redness, itching, or hives. Children, due to their smaller size, may experience more pronounced effects from exposure.

8.4 Potential Cytotoxicity of Isolated Compounds

Tectorigenin may exert certain cytotoxicity, which is related to the administration time and concentration.

8.5 Pregnancy and Lactation

Blue flag is deemed unsafe for certain populations, including pregnant or nursing women and young children.

8.6 Insufficient Clinical Pharmacology Data

Although the majority of preclinical studies have reported various pharmacological activities of I. germanica, sufficient clinical trials are not currently available. To draw a definitive conclusion about the efficacy and therapeutic activities of I. germanica and its bioactive compounds, further clinical and experimental studies are required. It is also necessary to focus on pharmacokinetic and safety studies on the extracts of I. germanica.

The toxicity of Belamcanda chinensis will require further study, and more attention should be devoted to its better utilization.

8.7 Bioavailability Limitation

Pharmacokinetic studies have demonstrated that the main metabolic pathways in rats for tectorigenin are glucuronidation, sulfation, demethylation, and methoxylation, but it exhibits poor bioavailability. This pharmacokinetic limitation is a key challenge in translating in vitro results to clinical benefit.

8.8 Hormonal Interactions

Isoflavone-like compounds in Iris preparations may interfere with hormone-sensitive conditions. Given the well-documented phytoestrogenic activity of tectorigenin and related isoflavones (as reviewed in the pharmacological literature), individuals with hormone-sensitive conditions should be aware of this potential interaction, though specific clinical drug-interaction studies are not available in the indexed literature.

References

Health Conditions

Health conditions that Iris may help support.

No conditions available.

Body Systems

Body systems that Iris may help support.

No body systems available.